66 /100
HIGH RISK
Score updated Jul 14, 2026

REVB — Revelation Biosciences, Inc. Dilution Risk Tracker

Track REVB dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track REVB — Get alerts when the score changes →

As of July 14, 2026, Revelation Biosciences, Inc. (REVB) has a DilutionWatch DilutionScore of 66/100, rated HIGH dilution risk. Revelation Biosciences, Inc. has a market capitalization of $4.28M, 3.91M shares outstanding, 13 institutional holders tracked. Key dilution vectors include 83.4K outstanding warrants, approximately 16 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
40
📊 Float Risk
27
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
41%
🔁 Convertible Conversion 60%
• Major convertible overhang: 58% potential dilution
• Convertible risk score very high (85/100)
🔄 Reverse Split 30%
• 50-day avg $1.13 approaching $1 threshold
📉 Score Deterioration 10%
• Score in HIGH risk zone (66/100)
🔔 Track REVB — Get forecast alerts →

💹 Market Data

Market Cap$4.28M
Shares Outstanding3.91M
Float3.44M
Cash$14.13M
Debt$759.0K
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 223.8% shares (2025Q4 vs prior)
13 institutional holders · 1.23M shares
#1 SABBY MANAGEMENT, LLC 605.7K shares
#2 ARMISTICE CAPITAL, LLC 434.3K shares
#3 CITADEL ADVISORS LLC 54.7K shares
+ 10 more holders Sign up free to view →

📉 Short Interest

Short Interest13.9K
Days to Cover1.0
% of Float0.4%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2022
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for REVB Shareholders

Revelation Biosciences, Inc. (REVB) has a DilutionScore of 66/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 14, 2026, updated from SEC EDGAR data.

Cash runway is a key watch item: REVB has approximately 16 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for REVB in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for REVB alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track REVB Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking REVB — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for REVB
📊 REVB FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 REVB Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.